DK0533483T3 - Fremgangsmåde til fremstilling af chlorsulfat og sulfamatderivater af 2,3:4,5-bis-O-(q-methylethyliden-beta-D-fruktopyranos - Google Patents

Fremgangsmåde til fremstilling af chlorsulfat og sulfamatderivater af 2,3:4,5-bis-O-(q-methylethyliden-beta-D-fruktopyranos

Info

Publication number
DK0533483T3
DK0533483T3 DK92308509T DK92308509T DK0533483T3 DK 0533483 T3 DK0533483 T3 DK 0533483T3 DK 92308509 T DK92308509 T DK 92308509T DK 92308509 T DK92308509 T DK 92308509T DK 0533483 T3 DK0533483 T3 DK 0533483T3
Authority
DK
Denmark
Prior art keywords
chlorosulfate
fructopyranose
methylethylidene
beta
bis
Prior art date
Application number
DK92308509T
Other languages
Danish (da)
English (en)
Inventor
Cynthia A Maryanoff
Kirk L Sorgi
Lorraine Scott
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Application granted granted Critical
Publication of DK0533483T3 publication Critical patent/DK0533483T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/34—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfuric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92308509T 1991-09-19 1992-09-18 Fremgangsmåde til fremstilling af chlorsulfat og sulfamatderivater af 2,3:4,5-bis-O-(q-methylethyliden-beta-D-fruktopyranos DK0533483T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76272091A 1991-09-19 1991-09-19
US92626992A 1992-08-05 1992-08-05

Publications (1)

Publication Number Publication Date
DK0533483T3 true DK0533483T3 (da) 1998-09-28

Family

ID=27117178

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92308509T DK0533483T3 (da) 1991-09-19 1992-09-18 Fremgangsmåde til fremstilling af chlorsulfat og sulfamatderivater af 2,3:4,5-bis-O-(q-methylethyliden-beta-D-fruktopyranos

Country Status (23)

Country Link
US (1) US5387700A (ja)
EP (1) EP0533483B1 (ja)
JP (1) JP3174410B2 (ja)
KR (1) KR100229180B1 (ja)
CN (1) CN1035820C (ja)
AT (1) ATE163937T1 (ja)
AU (1) AU651244B2 (ja)
CA (1) CA2078519C (ja)
DE (1) DE69224691T2 (ja)
DK (1) DK0533483T3 (ja)
EG (1) EG20164A (ja)
ES (1) ES2114917T3 (ja)
FI (1) FI107731B (ja)
GR (1) GR3026618T3 (ja)
HU (1) HU212634B (ja)
IL (1) IL103172A (ja)
MX (1) MX9205305A (ja)
MY (1) MY113564A (ja)
NO (1) NO179284C (ja)
NZ (1) NZ244409A (ja)
PH (1) PH31291A (ja)
TW (1) TW217413B (ja)
ZW (1) ZW14792A1 (ja)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3250777B2 (ja) * 1995-02-13 2002-01-28 セントラル硝子株式会社 イミド類、その塩類およびそれらの製造法
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
CA2362336C (en) * 1999-02-17 2005-04-12 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating essential tremor
US6420369B1 (en) 1999-05-24 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating dementia
PT1309324E (pt) * 2000-07-07 2006-06-30 Ortho Mcneil Pharm Inc Derivados de anticonvulsivos uteis para o tratamento e prevencao do desenvolvimento de diabetes mellitus do tipo ii e da sindroma x
JP2004505043A (ja) 2000-08-02 2004-02-19 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド うつ病の治療で用いるに有用な抗痙攣性誘導体
MXPA03003870A (es) * 2000-10-30 2004-08-12 Johnson & Johnson Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
CA2465952A1 (en) * 2001-11-06 2003-05-15 Ortho-Mcneil Pharmaceutical, Inc. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
BR0307951A (pt) * 2002-02-26 2004-12-21 Ortho Mcneil Pharm Inc Co-terapia para o tratamento de enxaqueca compreendendo derivados de anticonvulsivantes e agentes antienxaqueca
JP4906233B2 (ja) 2002-03-01 2012-03-28 ユニバーシティー オブ サウス フロリダ 少なくとも１種の有効薬剤成分を含有する多構成要素固相
US7060725B2 (en) * 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
US20040115262A1 (en) * 2002-07-29 2004-06-17 Frank Jao Formulations and dosage forms for controlled delivery of topiramate
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
CN100430408C (zh) * 2002-10-31 2008-11-05 奥索-麦克尼尔药品公司 制备吡喃果糖氨基磺酸酯衍生物的连续法
US7196209B2 (en) * 2002-10-31 2007-03-27 Ortho-Mcneil Pharmaceutical, Inc. Continuous process for the preparation of fructopyranose sulfamate derivatives
UA81657C2 (ru) * 2003-03-04 2008-01-25 Орто-Макнейл Фармасьютикел, Инк. Способ получения противосудорожных производных топирамата
WO2004108732A1 (en) * 2003-05-12 2004-12-16 Sun Pharmaceutical Industries Limited PROCESS FOR THE PREPARATION OF 2,3:4,5-BIS-O(1-METHYLETHYLIDENE)-ß-D-FRUCTOPYRANOSE SULFAMATE
AU2004264316A1 (en) * 2003-08-06 2005-02-24 Alza Corporation Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
JP2007503389A (ja) * 2003-08-22 2007-02-22 アルザ・コーポレーシヨン 長期間にわたるトピラメートの段階的送達
EP1701697A2 (en) * 2003-09-02 2006-09-20 ALZA Corporation Novel drug compositions and dosage forms of topiramate
KR20060120193A (ko) * 2003-11-14 2006-11-24 알자 코포레이션 액체 제형내 토피라메이트의 제어된 방출
KR20050062976A (ko) * 2003-12-19 2005-06-28 일동제약주식회사 2,3:4,5-비스-오-(1-메틸에틸리덴)-베타-디-프럭토피라노즈설파메이트의 새로운 개량된 제조방법
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
WO2005065648A2 (en) * 2003-12-29 2005-07-21 Alza Corporation, Inc., Novel drug compositions and dosage forms of topiramate
MXPA06007509A (es) * 2003-12-29 2007-10-18 Johnson & Johnson Composiciones de farmaco y formas de dosis novedosas.
US20050203287A1 (en) * 2004-03-11 2005-09-15 Chandrasekhar Batchu Process for the preparation of sulfamate derivatives
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AR049646A1 (es) * 2004-06-16 2006-08-23 Janssen Pharmaceutica Nv Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
MX2007002309A (es) * 2004-08-24 2007-10-08 Johnson & Johnson Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos.
WO2006041718A2 (en) * 2004-10-05 2006-04-20 Fallbrook Technologies, Inc. Continuously variable transmission
CA2609185A1 (en) * 2005-05-20 2006-11-30 Ahmed F. Abdel-Magid Process for preparation of sulfamide derivatives
BRPI0610210A2 (pt) * 2005-05-25 2010-06-01 Janssen Pharmaceutica Nv composições pediátricas de topiramato, uso das mesmas e recipiente
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US8497298B2 (en) * 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
AR058389A1 (es) * 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US20070191459A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels
US20070191449A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
US20070191461A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
US20070191453A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
WO2007099388A1 (en) * 2006-03-01 2007-09-07 Glade Organics Private Limited An improved process for the manufacture of topiramate
WO2007108009A1 (en) * 2006-03-17 2007-09-27 Alembic Limited A process for purification of topiramate
EP2026790A2 (en) * 2006-05-19 2009-02-25 Janssen Pharmaceutica, N.V. Co-therapy for the treatment of epilepsy and related disorders
JP5424571B2 (ja) * 2007-04-12 2014-02-26 協和発酵キリン株式会社 トピラマート含有固形製剤
CN101720397B (zh) * 2007-04-24 2013-01-02 福博科技术公司 电力牵引传动装置
CN101450951B (zh) * 2007-11-30 2012-10-10 重庆凯林制药有限公司 托吡酯的制备方法
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
MX2011000090A (es) 2008-06-23 2011-03-02 Janssen Pharmaceutica Nv Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]diox in-2-ilmetil)sulfamida.
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US8748594B2 (en) 2010-02-05 2014-06-10 Scinopharm Taiwan, Ltd. Process for the preparation and purification of topiramate
CN102936268A (zh) * 2012-11-13 2013-02-20 江苏吉贝尔药业有限公司 一种托吡酯中间体丙酮叉的制备方法
CN106397502A (zh) * 2016-08-31 2017-02-15 安徽省润生医药股份有限公司 一种托吡酯的合成工艺
CN108341844A (zh) * 2018-04-25 2018-07-31 广州小桔生物科技有限公司 一种高纯度托吡酯的制备方法
CN110655541A (zh) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯晶型
CN110655542A (zh) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯的晶型
EP3883546A1 (en) 2018-11-21 2021-09-29 Rosemont Pharmaceuticals Ltd Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
CN114350340B (zh) * 2022-01-13 2023-01-17 陕西科技大学 一种压裂用增渗剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582916A (en) * 1983-09-26 1986-04-15 Mcneilab, Inc. Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives

Also Published As

Publication number Publication date
PH31291A (en) 1998-07-06
NO923637D0 (no) 1992-09-18
ES2114917T3 (es) 1998-06-16
IL103172A (en) 1997-01-10
HUT63612A (en) 1993-09-28
KR100229180B1 (ko) 1999-11-01
DE69224691D1 (de) 1998-04-16
ATE163937T1 (de) 1998-03-15
EP0533483A2 (en) 1993-03-24
CA2078519A1 (en) 1993-03-20
US5387700A (en) 1995-02-07
ZW14792A1 (en) 1994-04-20
MY113564A (en) 2002-04-30
DE69224691T2 (de) 1998-08-20
FI924189A0 (fi) 1992-09-18
CA2078519C (en) 2003-09-16
TW217413B (ja) 1993-12-11
FI924189A (fi) 1993-03-20
NO179284C (no) 1996-09-11
HU9202974D0 (en) 1992-11-30
GR3026618T3 (en) 1998-07-31
FI107731B (fi) 2001-09-28
EP0533483B1 (en) 1998-03-11
AU2451892A (en) 1993-03-25
NZ244409A (en) 1995-02-24
CN1075317A (zh) 1993-08-18
EP0533483A3 (en) 1994-11-02
EG20164A (en) 1997-08-31
NO179284B (no) 1996-06-03
CN1035820C (zh) 1997-09-10
KR930006029A (ko) 1993-04-20
MX9205305A (es) 1993-07-01
IL103172A0 (en) 1993-02-21
NO923637L (no) 1993-03-22
HU212634B (en) 1996-09-30
JPH05230011A (ja) 1993-09-07
AU651244B2 (en) 1994-07-14
JP3174410B2 (ja) 2001-06-11

Similar Documents

Publication Publication Date Title
DK0533483T3 (da) Fremgangsmåde til fremstilling af chlorsulfat og sulfamatderivater af 2,3:4,5-bis-O-(q-methylethyliden-beta-D-fruktopyranos
FR2663784B1 (fr) Procede de realisation d'un etage d'un circuit integre.
DE59306602D1 (de) Verfahren zur herstellung von polycarboxylaten auf polysaccharid-basis
ATE211724T1 (de) Verfahren zur herstellung von 4-hydroxystyrol
BR9607149A (pt) Produção e recuperação de éter dimetílico a partir de metanol
EP0616994A3 (en) Process for the preparation of ether alcohols by hydrogenolysis of cyclic ketals.
DK0680968T3 (da) Fremgangsmåde til fremstilling af ginkgolid B fra ginkgolid C
DK0538345T3 (da) Fremgangsmåde til fremstilling af haloidglasemner
DK0451094T3 (da) Fremgangsmåde til fremstilling af pigmenter
FR2661872B1 (fr) Procede de fabrication d'un pare-soleil recouvert de tissu.
DK148060C (da) Fremgangsmaade til fremstilling af 5'-deoxy-5-fluoruridin
IT7829321A0 (it) Processo pert la preparazione di un copolimero di esteri vinilici.
DE69109910D1 (de) Herstellung von Ethyl-tert.alkyläthern.
FI900665A0 (fi) Derivat av 3-pyroglutamyl-tiatsolidin -4-karboxylsyra och deras farmakologiska egenskaper.
DK0455194T3 (da) Fremgangsmåde til fremstilling af et disazopigment
DE69409800D1 (de) Verfahren zur herstellung von halogenierten alkoholen
EP0637776A4 (en) PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING A RELIEF CONFIGURATION FROM THIS COMPOSITION.
DE3750978D1 (de) Verfahren zur Herstellung eines monolithisch integrierten Photoempfängers.
ATE128113T1 (de) Calicheamicinon, dessen abkömmlinge und analogen und verfahren zu deren herstellung.
ATE156131T1 (de) Verbessertes verfahren zur herstellung von 2- amino(2,3,5-tri-o-benzyl-beta-d- arabinofuranosyl)adenin
IS1743B (is) Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)metanól- og (1-fenýl-1-heterósýklýl)metýlamínafleiður
ATE126208T1 (de) Verfahren zur herstellung von alpha- ((dialkylamino)substituiertes-methylen)-beta-ox - (substituiertes)-propannitrile.
ESCHENAUER et al. The development and optimization of high-precision support panels
KR970046523U (ko) 패널의 스크린 공정중 위치 전환 불량 패널 배출장치